McKesson Corporation (NYSE:MCK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 10, Deutsche ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

If you are wondering whether McKesson still looks attractive after its strong run, or whether much of the potential upside is ...

McKesson saw strong 2025 growth from GLP-1 tailwinds, but fading momentum, weak margins, and a 21x forward P/E show ...

McKesson (MCK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Discover why McKesson (MCK) is a Buy: strong revenue, margin gains, and robust capital returns suggest 13.5% upside. Click here to read my most recent analysis.

McKesson Corporation (NYSE: MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss the company’s multi-year strategic priorities, ...

Jan. 7—There will be new life at the former McKesson plant in Shenango Township. CSI Container Services Inc. will relocate from its current location at 209 Green Ridge Road in Neshannock Township to ...

Pharmaceutical giant McKesson will pay a record $150 million civil penalty for alleged violations of the Controlled Substances Act, the Department of Justice announced Tuesday. This civil penalty ...

McKesson announced its revenue for the three-month period ended March 31 was $38.1 billion, up 25 percent from the $30.5 billion in revenues the company posted over the same period last year. For the ...